Selective A3 Adenosine Receptor Antagonist Radioligand for Human and Rodent Species.
Sign Up to like & getrecommendations! Published in 2022 at "ACS medicinal chemistry letters"
DOI: 10.1021/acsmedchemlett.1c00685
Abstract: The A3 adenosine receptor (A3AR) is a target for pain, ischemia, and inflammatory disease therapy. Among the ligand tools available are selective agonists and antagonists, including radioligands, but most high-affinity non-nucleoside antagonists are limited in… read more here.
Keywords: receptor antagonist; radioligand; adenosine receptor; receptor ... See more keywords